Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Spatz

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of Translational Medicine|March 3, 2005
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialBernard Escudier, Thierry Dorval, Nathalie Chaput, et al.
The Journal of Clinical Investigation|August 3, 2004
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effectsChristophe Borg, Magali Terme, Julien Taïeb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteriaAugustinus P T van der Ploeg, Alexander C J van Akkooi, Piotr Rutkowski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2009
EANM-EORTC general recommendations for sentinel node diagnostics in melanomaAnnette H Chakera, Birger Hesse, Zeynep Burak, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of Translational Medicine|March 3, 2005
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialBernard Escudier, Thierry Dorval, Nathalie Chaput, et al.
The Journal of Clinical Investigation|August 3, 2004
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effectsChristophe Borg, Magali Terme, Julien Taïeb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteriaAugustinus P T van der Ploeg, Alexander C J van Akkooi, Piotr Rutkowski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2009
EANM-EORTC general recommendations for sentinel node diagnostics in melanomaAnnette H Chakera, Birger Hesse, Zeynep Burak, et al.
Pageof 5